We identified the signaling pathway that causes NFkB hyperactivation downstream of p120ctn inactivation and EGFR overexpression; however, the key downstream targets of NFkB that lead to an aggressive type of ESCC are unknown. This evidence concerns the gene EGFR and esophageal squamous cell carcinoma.